milrinone has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehanna, OM | 1 |
| El Askary, A | 1 |
| Al-Shehri, S | 1 |
| El-Esawy, B | 1 |
| Milani, E | 1 |
| Nikfar, S | 1 |
| Khorasani, R | 1 |
| Zamani, MJ | 1 |
| Abdollahi, M | 1 |
| Goyal, RK | 1 |
| McNeill, JH | 1 |
3 other studies available for milrinone and Alloxan Diabetes
| Article | Year |
|---|---|
Effect of phosphodiesterase inhibitors on renal functions and oxidant/antioxidant parameters in streptozocin-induced diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hyperglycemia; Hypog | 2018 |
Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Lipid Peroxidation; Male; Milrinone; Oxidat | 2005 |
Effects of chronic streptozotocin-induced diabetes on the cardiac responses to milrinone.
Topics: Animals; Blood Glucose; Cardiotonic Agents; Diabetes Mellitus, Experimental; Dose-Response Relations | 1985 |